Literature DB >> 23411738

The optokinetic uncover test: a new insight into infantile esotropia.

Michael C Brodsky1, Lindsay Klaehn.   

Abstract

IMPORTANCE: We devised the optokinetic uncover test to examine the role of peripheral retinal motion input in generating horizontal optokinetic responses in patients with infantile strabismus.
OBJECTIVE: To ascertain whether subcortical visual input contributes to the asymmetrical monocular optokinetic responses that characterize infantile esotropia. DESIGN AND
SETTING: Observational study in an academic research setting. PARTICIPANTS: Ten patients with infantile esotropia. INTERVENTION: Optokinetic uncover test. MAIN OUTCOME MEASURES: Optokinetic testing was performed in 7 patients with isolated infantile esotropia (5 untreated and 2 previously treated) and in 3 patients with infantile esotropia syndrome associated with mild neurological disease. RESULTS All patients showed poor temporally directed optokinetic responses that instantaneously improved when the occluded esodeviated eye was uncovered, exposing it to nasally directed optokinetic motion. This improvement in optokinetic responses did not necessitate a fixation shift to the contralateral eye. CONCLUSIONS AND RELEVANCE: Nasally directed optokinetic input to the esodeviated eye can supplement temporal monocular optokinetic responses in the fixating eye under binocular conditions. This nonfoveal optokinetic contribution suggests that monocular nasotemporal optokinetic asymmetry is partly attributable to subcortical visuovestibular responses mediated by nonfoveal retina.

Entities:  

Mesh:

Year:  2013        PMID: 23411738     DOI: 10.1001/jamaophthalmol.2013.2348

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  1 in total

1.  Author Response: Motion Responses in Human Strabismus: What Optokinesis in the Deviating Eye Is Telling Us.

Authors:  Agaoglu S Agaoglu
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.